News
Gene Solutions has formalized a strategic collaboration with Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., a ...
Enables streamlined stability testing and release of higher quality AAV-based gene therapy products. - Provides much needed European capacity for AAV characterization and release. ROCKVILLE ...
Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has received GMP certification for Quality Control (QC ...
VGrid partnered with Wageningen University and Research, a global leader in controlled-environment agriculture, to conduct ...
The global Exosome Research Market, valued at US$189.4 million in 2024 stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a ...
aInstitute for Hygiene and Microbiology, University of Wuerzburg, Josef-Schneider-Str. 2 / E1, Wuerzburg 97080, Germany bInstitute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, ...
Here we report the development of a nanoliter qPCR platform to identify organohalogen-respiring bacteria and populations by quantifying major orthologous reductive dehalogenase gene groups. The qPCR ...
The Dallas Mavericks won the lottery on Monday and the right to select Duke freshman Cooper Flagg with the No. 1 overall pick in the 2025 NBA draft in Brooklyn, New York. The Mavericks, who finished ...
Canada's Sepset Biosciences Developing Point-of-Care Sepsis MDx With Eye Toward US Commercialization
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
aThe First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China bLuoyang Key Laboratory of Clinical Multiomics and Translational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results